EquityZen Growth Technology Fund LLC - Series 1140
Raised
$2M
Investors
54
Min Invest
$10,005
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 1140 is a Delaware pooled investment fund that raised $1.8M from 54 investors under Regulation D Rule 506(b), with a $10K minimum investment. Filed January 5, 2022, it is part of the EquityZen platform, which operates nearly 1,900 related pre-IPO investment vehicles managed by EquityZen Advisors LLC.
This pre-IPO fund uses the standard 506(b) private placement exemption with a low $10K minimum, typical of retail-accessible alternative investment platforms. The $33K average investor commitment and 54-investor syndicate reflect a retail-oriented structure common to special purpose vehicles targeting shares in private growth companies.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Richard Thoms
Executive Officer · Salt Lake City, UT
Assure Fund Management II LLC
Director · Salt Lake City, UT
Philip Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.